Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration

Status Recruiting

Clinical Trial Summary

The purpose is to investigate daptomycin pharmacokinetics in critically ill patients with suspected or verified bacteremia with Gram-positive cocci undergoing combined continuous hemodiafiltration at a filtration rate of 35ml/kg/h and to establish a dose recommendation for continuous hemodiafiltration at a filtrate rate of 35ml/kg/h.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Bacteremia

Clinical Trial Details

NCT number	NCT01171547
Study type	Interventional
Source	University of Zurich
Contact
Status	Recruiting
Phase	Phase 2
Start date	February 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03894046` - Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex	Phase 3
Active, not recruiting	`NCT03354338` - Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy	Phase 2
Withdrawn	`NCT02543957` - Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Completed	`NCT02210169` - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates	N/A
Completed	`NCT01410578` - The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO	N/A
Terminated	`NCT00428051` - Colombia Epidemiologic Surveillance Study	N/A
Completed	`NCT00609375` - Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen	Phase 4
Completed	`NCT00177736` - Pharmacodynamic Parameters of Two Different Doses of Cefepime	Phase 4
Terminated	`NCT00108433` - Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections	Phase 3
Completed	`NCT00571259` - Prophylactic Antimicrobial Catheter Lock	Phase 4
Completed	`NCT00027248` - Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections	Phase 3
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Recruiting	`NCT05950984` - Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Completed	`NCT03148769` - Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors
Completed	`NCT02536352` - Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being	Early Phase 1
Completed	`NCT02869191` - Blood Cultures's Profitability in Intensive Care Unit
Terminated	`NCT01734694` - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients	Phase 4
Completed	`NCT01179022` - Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions	N/A
Recruiting	`NCT00404625` - Infections Caused by ESbL-Producing Enterobacteriaceae in Italy	N/A
Completed	`NCT00398411` - Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells	Phase 3